Prognostic Value of KELIM Score and Inflammatory Markers in Ovarian Cancer

Clinical trial NCT07678008 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07678008
Sponsor: Aya Ahmed Nasser
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy High-grade Serous Ovarian Carcinoma

Start date: 2026-06-01
Primary completion: 2027-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.